scispace - formally typeset
B

Bhagteshwar Singh

Researcher at University of Liverpool

Publications -  31
Citations -  1923

Bhagteshwar Singh is an academic researcher from University of Liverpool. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 18 publications receiving 1112 citations. Previous affiliations of Bhagteshwar Singh include Christian Medical College & Hospital & Royal Liverpool University Hospital.

Papers
More filters
Journal ArticleDOI

Provisional case definitions for COVID-19-associated neurological disease - Authors' reply.

TL;DR: Its description aligns closely with the “acute respiratory infection” definition used to prompt testing for COVID-19 in earlier WHO and national guidelines, and there are additional challenges in thinking about causality when results are from specimens collected outside the CNS.
Journal ArticleDOI

Adequacy of Rifampin Absorption after Jejunostomy Tube Administration.

TL;DR: This report represents the first documented evidence, to the authors' knowledge, of adequate rifampin absorption when administered via PEJ tube and provides important reassurance for health care providers, patients, and families facing similar clinical scenarios.
Journal ArticleDOI

Using the BTS CAP audit to evaluate local data

TL;DR: Local mortality rates for severe CAP (CURB65 3-5) were 21.4% versus 42.6% nationally and provoked an examination of local severe CAP admissions between December 2009 and December 2009.
Journal ArticleDOI

Treatment of COVID-19 Acute Respiratory Distress Syndrome With a Tabletop Noninvasive Ventilation Device in a Respiratory Intermediate Care Unit

TL;DR: In this article , the outcomes of noninvasive ventilation (NIV) administered through a tabletop device for coronavirus disease 2019 acute respiratory distress syndrome in the respiratory intermediate care unit (RIMCU) at a tertiary care hospital in India were studied.
Journal ArticleDOI

Favipiravir for treating COVID-19

TL;DR: This protocol is a protocol for a Cochrane Review (intervention) to determine the efficacy and safety of favipiravir in patients with COVID-19 as compared to standard of care without favipIRavir.